GlassScriptPhysician profile
Ravi F Sood
NPI 1548559222
$4,340.20
in general payments reported to CMS, 2019-2025
11 companies · $961 in 2025
The $961 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,223 · 2022: $1,224 · 2023: $541 · 2024: $392 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,279.13 | 2022-2025 | |
| Summit Surgical Corp. | $1,223.04 | 2021 | |
| Innovation Technologies INC | $381.37 | 2024-2025 | Irrisept |
| Polynovo North America LLC | $356.71 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $325.46 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Axogen | $212.40 | 2025 | |
| Motiva USA, LLC | $142.04 | 2025 | |
| Skeletal Dynamics INC | $140.74 | 2023 | Geminus, Align, Implate |
| Stryker Corporation | $129.23 | 2023 | Variax |
| Integra Lifesciences Corporation | $125.80 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $24.28 | 2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.